Clinical Trials Directory

Trials / Completed

CompletedNCT04121052

A Study in Healthy Volunteers to Assess the Effect of Different Types of Food on a Single-dose of JNJ-64417184 Administered as Tablets

A Phase 1, 4-Period, Crossover, Open-label Study in Healthy Volunteers to Assess the Effect of Different Types of Food on a Single-dose of JNJ-64417184 Administered as Tablets

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Janssen Research & Development, LLC · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the effect of 5 different food conditions on the single dose pharmacokinetics (PK) of the JNJ-64417184 tablet formulation administered orally, using the PK after a high-fat meal as a reference, in healthy adult participants.

Conditions

Interventions

TypeNameDescription
DRUGJNJ-64417184Participants will receive single dose of JNJ-64417184 as oral tablet.

Timeline

Start date
2019-10-08
Primary completion
2019-12-23
Completion
2019-12-23
First posted
2019-10-09
Last updated
2020-01-28

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04121052. Inclusion in this directory is not an endorsement.